(Q54091226)

English

Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

T L Vischer

1

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

publication date

1 September 1990

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

9

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

3

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

356-361

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

The treatment of rheumatoid arthritis with OM-8930, a bacterial immunostimulating agent.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole in rheumatoid arthritis--a multivariate analysis of a multicentric study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of cytokine production and natural killer activity by an Escherichia coli extract

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Auranofin versus placebo in the treatment of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of a bacterial extract on cellular and humoral immune responses in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of the humoral immune response and resistance to bacterial infection in mice by the oral administration of a bacterial immunomodulator (OM-89).

1 reference

https://pubmed.ncbi.nlm.nih.gov/2261735

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02114396

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 May 2018

http://europepmc.org/abstract/MED/2261735

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54091226&oldid=1380796434"